Prothena Co. plc Given Consensus Recommendation of Moderate Buy by Brokerages
PRTA Stock | USD 14.15 0.40 2.75% |
About 66% of Prothena Plc's investor base is looking to short. The analysis of the overall investor sentiment regarding Prothena plc suggests that many traders are alarmed. The current market sentiment, together with Prothena Plc's historical and current headlines, can help investors time the market. In addition, many technical investors use Prothena plc stock news signals to limit their universe of possible portfolio assets.
Prothena |
Shares of Prothena Co. plc have received a consensus recommendation of Moderate Buy from the seven ratings firms that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month
Read at thelincolnianonline.com
Prothena Plc Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Prothena Plc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Prothena Plc Fundamental Analysis
We analyze Prothena Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prothena Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prothena Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earnings To Growth
Price To Earnings To Growth Comparative Analysis
Prothena Plc is currently under evaluation in price to earnings to growth category among its peers. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Prothena plc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Prothena Plc stock to make a market-neutral strategy. Peer analysis of Prothena Plc could also be used in its relative valuation, which is a method of valuing Prothena Plc by comparing valuation metrics with similar companies.
Peers
Prothena Plc Related Equities
ACLX | Arcellx | 5.73 | ||||
MDGL | Madrigal Pharmaceuticals | 0.48 | ||||
MIST | Milestone Pharmaceuticals | 1.06 | ||||
ONCY | Oncolytics Biotech | 1.16 | ||||
PCVX | Vaxcyte | 1.18 | ||||
ETNB | 89bio | 1.87 | ||||
PLRX | Pliant Therapeutics | 2.18 | ||||
SCPH | Scpharmaceuticals | 2.35 | ||||
STOK | Stoke Therapeutics | 2.70 | ||||
MCRB | Seres Therapeutics | 2.80 | ||||
IMCR | Immunocore Holdings | 3.39 | ||||
CGEM | Cullinan Oncology | 3.43 | ||||
VRDN | Viridian Therapeutics | 3.58 | ||||
KNSA | Kiniksa Pharmaceuticals | 3.88 | ||||
NUVL | Nuvalent | 7.04 | ||||
VTYX | Ventyx Biosciences | 10.07 |
Complementary Tools for Prothena Stock analysis
When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |